Thomas F Whayne1. Show Affiliations » 1. Gill Heart Institute, University of Kentucky, Lexington, KY, USA twhayn0@uky.edu.
Abstract
Entities: Disease Gene Mutation
Mesh: See more » AnimalsBiomarkers/bloodComorbidityDietary SupplementsGene FrequencyGenetic Predisposition to DiseaseHealth StatusHomocysteine/bloodHumansHyperhomocysteinemia/bloodHyperhomocysteinemia/drug therapyHyperhomocysteinemia/enzymologyHyperhomocysteinemia/epidemiologyHyperhomocysteinemia/geneticsHypertension/epidemiologyMethylenetetrahydrofolate Reductase (NADPH2)/geneticsPhenotypePolymorphism, GeneticRisk AssessmentRisk FactorsTreatment OutcomeVenous Thromboembolism/bloodVenous Thromboembolism/enzymologyVenous Thromboembolism/epidemiologyVenous Thromboembolism/geneticsVenous Thromboembolism/prevention & controlVitamin B Complex/therapeutic use
Substances: See more » BiomarkersHomocysteineVitamin B ComplexMTHFR protein, humanMethylenetetrahydrofolate Reductase (NADPH2)
Year: 2014 PMID: 25168958 DOI: 10.1177/0003319714548871
Source DB: PubMed Journal: Angiology ISSN: 0003-3197 Impact factor: 3.619